Years active
—
Total patents
2
Frequent collaborator
Ulrike Gnad-Vogt
Domains
biotechpharmaceuticaloncologygene_editing
Patents
2
US 20160166668·Curevac AG
How an mRNA Vaccine Targets Prostate Cancer with Six Antigens
This patent describes an mRNA vaccine designed to treat prostate cancer by delivering genetic instructions for a specific combination of six prostate-related proteins, teaching the body to fight the cancer.
US 20160168227·Curevac AG
Composition and vaccine for treating lung cancer
Patent monitoring
Get a weekly digest when new patents naming Karl-Josef Kallen are indexed.